Drugs / Shenyankangfu tablets
Shenyankangfu tablets
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02063100 | Feb 2014 → Jul 2015 | glomerulonephritis, proteinuria | Chinese PLA General Hospital | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Shenyankangfu tablets | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02063100 ↗ |
| Known as | Shenyankangfu Tablet | “Shenyankangfu Tablet (SYKFT) is a Chinese patent medicine” PMID 33589406 ↗ Jan 2021 |
| Known as | SYKFT | “Shenyankangfu Tablet (SYKFT) is a Chinese patent medicine” PMID 33589406 ↗ Jan 2021 |
| Modality | Traditional medicine (herbal / TCM) | “Shenyankangfu Tablet (SYKFT) is a Chinese patent medicine” PMID 33589406 ↗ Jan 2021 |
| Route | Oral | “Shenyankangfu tablets 2.4g, po, 3/day” NCT02063100 ↗ |